TRAVELING THE WORLD, WRITING WHAT THE PEOPLE NEED TO KNOW.
TRAVELING THE WORLD, WRITING WHAT THE PEOPLE NEED TO KNOW.
As the United States Drug Enforcement Agency (DEA) continues to display its arrogance, refusing to remove marijuana from schedule 1 of the Control Substance Act (CSA), thanks to certified professional bodies in the country, more and more details on medical efficacy of the plant is being revealed. On August 11, 2016 the DEA turned down two Read More…
Facets of the anima [20K Leagues Under the Sea] “The sea is everything. It covers seven-tenths of the terrestrial globe. Its breath is pure and healthy. It is an immense desert, where man is never lonely, for he feels life stirring on all sides. The sea is only the embodiment of a supernatural and wonderful Read More…
News circulated recently that the DEA had rescheduled cannabidiol (CBD), the nonpsychoactive ingredient in cannabis, but the technicalities of the agency’s decision actually show their ruling is highly restrictive. The decision concerned a recently FDA-approved pharmaceutical version of CBD, produced by GW Pharmaceuticals. Due to the federal government’s continued prohibition of cannabis Epidiolex was prohibited from going to market unless the Read More…
Last week the hemp industry in the United States faced a roadblock after the federal U.S. 9th Circuit Court of Appeals upheld a decision by the Drug Enforcement Agency (DEA) to list cannabidiol or CBD as a Schedule 1 controlled substance under the Controlled Substances Act. It’s worth pointing out that CBD has no psychoactive effects Read More…
“I’m willing to face the jail time or the consequences for it if it will help my son,” said a mother who was arrested for letting her son use cannabis to treat his seizures. Macon, GA – (TFTP) A teenager who suffers from seizures was forcibly separated from his parents and put into state custody, while his parents Read More…
A federal appeals court ruled against the thousands of people who have experienced the life-saving effects of CBD oil by upholding the decision that the substance is a Schedule 1 drug. Washington, D.C. – (TFTP) The United States hemp industry was dealt a major blow on Monday after the federal U.S. 9th Circuit Court of Appeals upheld a Read More…